Concepedia

A Irtiza-Ali

AI

Statistics

Publications

2

Citations

112

H-Index

2

Active since

2004

Affiliations

Boehringer Ingelheim (Germany)(Current)

A Irtiza-Ali is an author at Boehringer Ingelheim (Germany).

Publications per year

2004–2023

2

Publications

2

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 88 citations · Full text

Blood Pressure and the Cystic Fibrosis Gene

Maurice Super, A Irtiza-Ali, Stephen A. Roberts et al. · Hypertension · 2004 · 24 citations

1–2 of 2